Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Carvepen tablet 6.25 mg

Approval Number

SIN13412P

Drug Name

Carvepen tablet 6.25 mg

Product Name

Carvepen tablet 6.25 mg

Approval Date

February 25, 2008

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

C07AG02

ATC Item Name

carvedilol

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

Elpen Pharmaceutical Co.Inc

Active Ingredients

Ingredient Name

Carvedilol

Strength

6.25 mg

Drug MonographCarvedilol

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy